ArticleFrontiers in oncology2022

Adjuvant chemoradiotherapy does not improve outcomes in patients with fistula-associated anal adenocarcinoma undergoing abdominoperineal resection.

Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.